Trial
NCT02489123
Enzalutamide in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Washington
Collaborators
National Cancer Institute (NCI); National Comprehensive Cancer Network
Condition
Ann Arbor Stage I Mantle Cell Lymphoma
Intervention
Enzalutamide
Why stopped
Accrual goal not met
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-08-10